Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

38.52
Delayed Data
As of 3:59pm ET
 -2.47 / -6.03%
Today’s Change
33.50
Today|||52-Week Range
99.46
-40.67%
Year-to-Date
The 1 Stock You've Been Overlooking for Your Roth IRA
Aug 11 / MotleyFool.com - Paid Partner Content
Agios (AGIO) Q2 Loss Wider than Expected, Pipeline in Focus
Aug 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close40.99
Today’s open41.12
Day’s range38.11 - 42.17
Volume904,271
Average volume (3 months)702,953
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)-55.87%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...-0.02-0.16%
LXRXLexicon Pharmaceutic...-0.93-6.02%
PCRXPacira Pharmaceutica...-3.54-8.16%
ALDRAlder Biopharmaceuti...-2.27-6.81%
Data as of 3:59pm ET, 08/24/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.49
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Senior Vice President-Finance &
Contact Person
Glenn Goddard
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs